To estimate the association between a cancer diagnosis and the use of healthcare services and medication among cancer survivors (CS) and their partners (PCS), particularly in the first years after diagnosis.
This is a cross-sectional study based on data from the Fourth Wave of the Survey of Health, Ageing and Retirement in Europe—SHARE (2010–2011); it included individuals aged ≥ 50 years and their partners, from 16 European countries. All CS diagnosed with a first primary cancer within 10 years (n = 1174) and corresponding PCS (n = 1174) were country-, sex-, age- and education-matched (1:3) with non-cancer individuals (NC) and partners of non-cancer individuals (PNC), respectively. Adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) were computed.
Healthcare use in the previous 12 months and current medication intake were more frequent among CS than NC; the ORs (95% CIs) were 2.56 (2.23–2.94) for ≥ 8 medical contacts, 3.07 (2.62–3.59) for hospital stays and 1.75 (1.52–2.03) for use of ≥ 3 drugs indicated for different health problems. Medical contacts (OR = 5.74, 95% CI 4.31–7.65) and hospitals stays (OR = 13.88, 95% CI 10.15–18.98) were more frequent among CS diagnosed in the last 2 years. Contacts with medical doctors (≥ 8; OR = 1.23, 95% CI 1.06–1.42) were also more common among PCS than PNC.
When compared to individuals without cancer, CS diagnosed in the last 10 years, as well as their partners, had an increased healthcare use.
Implication for Cancer Survivors
These findings highlight the importance of family-focused care in oncological settings, in order to support patients as well as their partners, who are frequently their closest significant person.
This is a preview of subscription content,to check access.
Access this article
Ferlay J, Colombet M, Bray F. Cancer incidence in five continents, CI5plus: IARC CancerBase no. 9 [internet]. International Agency for Research on Cancer: Lyon, France; 2018. Available from: http://ci5.iarc.fr. Accessed 15 May 2019
UN Population Division. World population prospects: the 2012 revision - vol I, comprehensive tables (ST/ESA/SER.A/336). New York: UN Department of Economic and Social Affairs; 2013.
Araujo F, Gouvinhas C, Fontes F, La Vecchia C, Azevedo A, Lunet N. Trends in cardiovascular diseases and cancer mortality in 45 countries from five continents (1980-2010). Eur J Prev Cardiol. 2013;21(8):1004–17.
Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998–2005.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global cancer observatory: cancer today. International Agency for Research on Cancer: Lyon, France; 2018. Available from: https://gco.iarc.fr/today. Accessed 15 May 2019
Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Committee on Cancer Survivorship: improving care and quality of life. Institute of Medicine and National Research Council, editor. Washington, DC: National Academies Press; 2006.
Kim Y, Shaffer KM, Carver CS, Cannady RS. Quality of life of family caregivers 8 years after a relative’s cancer diagnosis: follow-up of the National Quality of Life Survey for Caregivers. Psychooncology. 2016;25(3):266–74.
Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14(8):721–32.
Hawkins NA, Soman A, Buchanan Lunsford N, Leadbetter S, Rodriguez JL. Use of medications for treating anxiety and depression in cancer survivors in the United States. J Clin Oncol. 2017;35(1):78–85.
Jansson MRN, von Heymann-Horan A, Rasmussen BK, Albieri V, Frederiksen K, Suppli N, et al. Risk for use of antidepressants, anxiolytics, and hypnotics in partners of glioma patients-a nationwide study covering 19 years of prescriptions. Psychooncology. 2018;27(8):1930–6.
Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112(11 Suppl):2577–92.
Goren A, Gilloteau I, Lees M, DaCosta Dibonaventura M. Quantifying the burden of informal caregiving for patients with cancer in Europe. Support Care Cancer. 2014;22(6):1637–46.
Huang IC, Hudson MM, Robison LL, Krull KR. Differential impact of symptom prevalence and chronic conditions on quality of life in cancer survivors and non-cancer individuals: a population study. Cancer Epidemiol Biomark Prev. 2017;26(7):1124–32.
Heins M, Schellevis F, Rijken M, van der Hoek L, Korevaar J. Determinants of increased primary health care use in cancer survivors. J Clin Oncol. 2012;30(33):4155–60.
Pacheco-Figueiredo L, Lunet N. Health status, use of healthcare, and socio-economic implications of cancer survivorship in Portugal: results from the Fourth National Health Survey. J Cancer Surviv. 2014;8(4):611–7.
Heins M, Schellevis F, Rijken M, Donker G, van der Hoek L, Korevaar J. Partners of cancer patients consult their GPs significantly more often with both somatic and psychosocial problems. Scand J Prim Health Care. 2013;31(4):203–8.
Sjovall K, Attner B, Lithman T, Noreen D, Gunnars B, Thome B, et al. Influence on the health of the partner affected by tumor disease in the wife or husband based on a population-based register study of cancer in Sweden. J Clin Oncol. 2009;27(28):4781–6.
Mollerberg ML, Sandgren A, Lithman T, Noreen D, Olsson H, Sjovall K. The effects of a cancer diagnosis on the health of a patient’s partner: a population-based registry study of cancer in Sweden. Eur J Cancer Care (Engl). 2016;25(5):744–52.
Ekwueme DU, Yabroff KR, Guy GP Jr, Banegas MP, de Moor JS, Li C, et al. Medical costs and productivity losses of cancer survivors--United States, 2008-2011. MMWR Morb Mortal Wkly Rep. 2014;63(23):505–10.
Maddams J, Utley M, Moller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer. 2012;107(7):1195–202.
Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.
Borsch-Supan A, Brandt M, Hunkler C, Kneip T, Korbmacher J, Malter F, et al. Data resource profile: the Survey of Health, Ageing and Retirement in Europe (SHARE). Int J Epidemiol. 2013;42(4):992–1001.
Bergmann M, Kneip T, De Luca G, Scherpenzeel A. Survey participation in the Survey of Health, Ageing and Retirement in Europe (SHARE), Wave 1-6. Based on Release 6.0.0 (March 2017). Munich: Munich Center for the Economics of Aging (MEA); 2017.
SHARE Wave 4: innovations & methodology. Malter F, Börsch-Supan A, editors. Munich: MEA, Max Planck Institute for Social Law and Social Policy; 2013.
United Nations Educational Scientific and Cultural Organization. International standard classification of education (ISCED-1997) - re-edition. Montreal: UNESCO-UIS; 2006.
National Coalition for Cancer Survivorship. History of NCCS 2019 [Available from: https://www.canceradvocacy.org/about-us/our-history/]. Accessed 1 March 2020
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol. 2014;15(1):23–34.
Prince MJ, Reischies F, Beekman AT, Fuhrer R, Jonker C, Kivela SL, et al. Development of the EURO-D scale--a European, union initiative to compare symptoms of depression in 14 European centres. Br J Psychiatry. 1999;174:330–8.
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–7.
Heins MJ, Korevaar JC, Rijken PM, Schellevis FG. For which health problems do cancer survivors visit their general practitioner? Eur J Cancer. 2013;49(1):211–8.
Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomark Prev. 2006;15(11):2020–6.
Moser RP, Arndt J, Han PK, Waters EA, Amsellem M, Hesse BW. Perceptions of cancer as a death sentence: prevalence and consequences. J Health Psychol. 2014;19(12):1518–24.
Lebel S, Tomei C, Feldstain A, Beattie S, McCallum M. Does fear of cancer recurrence predict cancer survivors’ health care use? Support Care Cancer. 2013;21(3):901–6.
Given BA, Given CW, Kozachik S. Family support in advanced cancer. CA Cancer J Clin. 2001;51(4):213–31.
Luppa M, Sikorski C, Motzek T, Konnopka A, Konig HH, Riedel-Heller SG. Health service utilization and costs of depressive symptoms in late life - a systematic review. Curr Pharm Des. 2012;18(36):5936–57.
Northouse L, Williams AL, Given B, McCorkle R. Psychosocial care for family caregivers of patients with cancer. J Clin Oncol. 2012;30(11):1227–34.
Williams AL. Psychosocial burden of family caregivers to adults with cancer. Recent Results Cancer Res. 2014;197:73–85.
Northouse LL, Mood DW, Montie JE, Sandler HM, Forman JD, Hussain M, et al. Living with prostate cancer: patients’ and spouses’ psychosocial status and quality of life. J Clin Oncol. 2007;25(27):4171–7.
Bergmann MM, Calle EE, Mervis CA, Miracle-McMahill HL, Thun MJ, Heath CW. Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol. 1998;147(6):556–62.
Navarro C, Chirlaque MD, Tormo MJ, Perez-Flores D, Rodriguez-Barranco M, Sanchez-Villegas A, et al. Validity of self reported diagnoses of cancer in a major Spanish prospective cohort study. J Epidemiol Community Health. 2006;60(7):593–9.
Ritter PL, Stewart AL, Kaymaz H, Sobel DS, Block DA, Lorig KR. Self-reports of health care utilization compared to provider records. J Clin Epidemiol. 2001;54(2):136–41.
Wallihan DB, Stump TE, Callahan CM. Accuracy of self-reported health services use and patterns of care among urban older adults. Med Care. 1999;37(7):662–70.
The SHARE data collection has been funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812), FP7 (SHARE-PREP: GA N°211909, SHARE-LEAP: GA N°227822, SHARE M4: GA N°261982) and Horizon 2020 (SHARE-DEV3: GA N°676536, SERISS: GA N°654221) and by DG Employment, Social Affairs & Inclusion. Additional funding from the German Ministry of Education and Research, the Max Planck Society for the Advancement of Science, the U.S. National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064, HHSN271201300071C) and from various national funding sources is gratefully acknowledged (see www.share-project.org).
This study was funded by national funding from the Foundation for Science and Technology—FCT (Portuguese Ministry of Science, Technology and Higher Education), under the Unidade de Investigação em Epidemiologia—Instituto de Saúde Pública da Universidade do Porto (EPIUnit) (UIDB/04750/2020). An individual PhD grant attributed to ARC (SFRH/BD/102181/2014) was co-funded by FCT and the Programa Operacional Capital Humano (POCH/FSE).
Conflict of interest
The authors declare that they have no conflicts of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Ethics Committee at the University of Mannheim approved Waves 1 to 4. The Fourth Wave was approved by the Ethics Council of the Max-Planck-Society. Additionally, whenever required, the implementation of SHARE in each country was approved by the respective ethics committees or institutional review boards.
Informed consent was obtained from all individual participants included in the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Costa, A.R., Alves, L. & Lunet, N. Healthcare services and medication use among cancer survivors and their partners: a cross-sectional analysis of 16 European countries. J Cancer Surviv 14, 720–730 (2020). https://doi.org/10.1007/s11764-020-00886-8